MedTrace Logo MedTrace
Clinical Trials News Drugs Diseases Companies About

Chronic Weight Management

  1. Home
  2. Diseases
  3. Chronic Weight Management
  4. Clinical Trials

Clinical Trials Related to Chronic Weight Management

Related studies linked through entity extraction aliases.

NCT07002905

A Study to Evaluate the Efficacy, Safety, and Tolerability in Participants With Obesity or Overweight With Weight-Related Comorbidities

Status
COMPLETED
Phase
PHASE2

NCT06972992

A Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ASC47 in Combination With Semaglutide

Status
COMPLETED
Phase
PHASE1

NCT06703021

A Dose-Range Study of Aleniglipron (GSBR-1290) in Participants Living With Obesity or Overweight With at Least One Weight-related Comorbidity

Status
COMPLETED
Phase
PHASE2

NCT06679959

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of ASC30 Injection in Participants With Obesity

Status
ACTIVE_NOT_RECRUITING
Phase
PHASE1/PHASE2

NCT06671821

Long-term Efficacy and Safety of HRS-7535 Tablets in Obese Subjects

Status
COMPLETED
Phase
PHASE2

NCT06427590

A Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ASC47 in Healthy and Obese Subjects

Status
COMPLETED
Phase
PHASE1

NCT01987427

A Multicenter, Double-blind, Randomized, Parallel-group, Pilot Study of 12-week Duration to Assess the Short-term Safety and Tolerability of Lorcaserin Plus Two Doses of Immediate-Release Phentermine-HCl Compared With Lorcaserin Alone in Overweight and Obese Adults

Status
COMPLETED
Phase
PHASE4

Clinical Trials

Explore studies by the year of their last update.

  • 2026
  • 2025
  • 2024
  • 2023
  • 2022
  • 2021
  • 2020
  • 2019
  • 2018
  • 2017
  • 2016
  • 2015
  • 2014
  • 2013
  • 2012
  • 2011
  • 2010
  • 2009
  • 2008
  • 2007
  • 2006
  • 2005

News & Analysis

Latest news and insights on clinical trials and medical research.

Browse All News →
MedTrace Logo MedTrace
About Privacy Policy Terms of Service Medical Disclaimer

© 2026 MedTrace.
Open-access medical & pharmaceutical data intelligence.